Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Validation of automated latex von Willebrand factor activity assay in a new prospective study including post-treatment patient samples.

Ettel M, Nardi MA, McVoy L.

Int J Lab Hematol. 2017 Jun;39(3):286-292. doi: 10.1111/ijlh.12622. Epub 2017 Jan 25.

PMID:
28120508
2.

Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand.

Valdes V, Nardi MA, Elbaum L, Berger JS.

J Thromb Thrombolysis. 2015 Jul;40(1):83-7. doi: 10.1007/s11239-015-1179-5.

3.

Platelet aggregation and coagulation factors in orthopedic surgery.

Oberweis BS, Cuff G, Rosenberg A, Pardo L, Nardi MA, Guo Y, Dweck E, Marshall M, Steiger D, Stuchin S, Berger JS.

J Thromb Thrombolysis. 2014 Nov;38(4):430-8. doi: 10.1007/s11239-014-1078-1.

PMID:
24874897
4.

Mean platelet volume reproducibility and association with platelet activity and anti-platelet therapy.

Shah B, Valdes V, Nardi MA, Hu L, Schrem E, Berger JS.

Platelets. 2014;25(3):188-92. doi: 10.3109/09537104.2013.793794. Epub 2013 Jun 20.

5.

Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study.

O'Brien M, Montenont E, Hu L, Nardi MA, Valdes V, Merolla M, Gettenberg G, Cavanagh K, Aberg JA, Bhardwaj N, Berger JS.

J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):280-8. doi: 10.1097/QAI.0b013e31828a292c.

6.

A new α1-globin mutation, Hb Brugg [α20(B1)His→Gln].

Rizzi M, Zurbriggen K, Schmid M, Goede JS, Nardi MA, Schmugge M, Speer O.

Hemoglobin. 2011;35(4):417-22. doi: 10.3109/03630269.2011.594138.

PMID:
21797708
7.

Centrifugation speed affects light transmission aggregometry.

Merolla M, Nardi MA, Berger JS.

Int J Lab Hematol. 2012 Feb;34(1):81-5. doi: 10.1111/j.1751-553X.2011.01360.x. Epub 2011 Jul 27.

8.

The inhibition effect of anti-GPIIIa49-66 antibody on megakaryocyte differentiation.

Pan R, Wang J, Nardi MA, Li Z.

Thromb Haemost. 2011 Sep;106(3):484-90. doi: 10.1160/TH11-03-0153. Epub 2011 Jun 28.

PMID:
21713325
9.

HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia.

Wang J, Zhang W, Nardi MA, Li Z.

J Thromb Haemost. 2011 Mar;9(3):562-73. doi: 10.1111/j.1538-7836.2010.04168.x.

10.

Specific cross-reaction of anti-dsDNA antibody with platelet integrin GPIIIa49-66.

Zhang W, Dang S, Wang J, Nardi MA, Zan H, Casali P, Li Z.

Autoimmunity. 2010 Dec;43(8):682-9. doi: 10.3109/08916934.2010.506207. Epub 2010 Sep 9.

11.

Dissolution of arterial platelet thrombi in vivo with a bifunctional platelet GPIIIa49-66 ligand which specifically targets the platelet thrombus.

Zhang W, Li YS, Nardi MA, Dang S, Yang J, Ji Y, Li Z, Karpatkin S, Wisniewski T.

Blood. 2010 Sep 30;116(13):2336-44. doi: 10.1182/blood-2010-01-264358. Epub 2010 Jun 4.

12.

Clinical and molecular genetic analysis of a family with macrothrombocytopenia and early onset sensorineural hearing loss.

Mhatre AN, Janssens S, Nardi MA, Li Y, Lalwani AK.

Eur J Med Genet. 2009 Jul-Aug;52(4):185-90. doi: 10.1016/j.ejmg.2009.02.010. Epub 2009 Mar 12.

PMID:
19285578
13.

C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke.

Li Z, Nardi MA, Li YS, Zhang W, Pan R, Dang S, Yee H, Quartermain D, Jonas S, Karpatkin S.

Blood. 2009 Jun 11;113(24):6051-60. doi: 10.1182/blood-2008-07-170571. Epub 2009 Feb 13.

14.

Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia.

Zhang W, Nardi MA, Borkowsky W, Li Z, Karpatkin S.

Blood. 2009 Apr 23;113(17):4086-93. doi: 10.1182/blood-2008-09-181073. Epub 2008 Nov 20.

15.

Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta3 integrin.

Li Z, Nardi MA, Wu J, Pan R, Zhang W, Karpatkin S.

J Biol Chem. 2008 Feb 8;283(6):3224-30. Epub 2007 Dec 3.

17.

Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia.

Li Z, Nardi MA, Karpatkin S.

Blood. 2005 Jul 15;106(2):572-6. Epub 2005 Mar 17.

18.
22.

Heterogenous inhibition of platelet aggregation by monoclonal antibodies binding to multiple sites on GPIIIa.

Liu LX, Nardi MA, Nierodzik ML, Karpatkin S.

Br J Haematol. 1995 Dec;91(4):976-82.

PMID:
8547151
23.

Production of a human anti-CD4 monoclonal antibody with antiidiotype to anti-HIV type 1 glycoprotein 120.

Karpatkin S, Nardi MA, Liu LX, Kouri YH, Borkowsky W.

AIDS Res Hum Retroviruses. 1995 Apr;11(4):509-15.

PMID:
7632465
24.
25.

A monoclonal antibody (LK-4) which differentiates PLA1 from PLA2 platelet extracts but not intact platelets.

Liu LX, Nardi MA, Flug F, Karpatkin S.

Thromb Res. 1992 May 15;66(4):309-20.

PMID:
1384161
26.
27.

Immunologic thrombocytopenic purpura after heterosexual transmission of human immunodeficiency virus (HIV).

Karpatkin S, Nardi MA, Hymes KB.

Ann Intern Med. 1988 Aug 1;109(3):190-3.

PMID:
3389601
29.

Thrombocytopenic purpura in narcotics addicts.

Savona S, Nardi MA, Lennette ET, Karpatkin S.

Ann Intern Med. 1985 Jun;102(6):737-41.

PMID:
2986504
30.

On the mechanism of thrombocytopenic purpura in sexually active homosexual men.

Walsh CM, Nardi MA, Karpatkin S.

N Engl J Med. 1984 Sep 6;311(10):635-9.

PMID:
6540841
31.

Leukocyte-platelet interactions in a murine model of Chediak-Higashi syndrome.

Kaplan SS, Boggs SS, Nardi MA, Basford RE, Holland JM.

Blood. 1978 Oct;52(4):719-25.

PMID:
687827

Supplemental Content

Loading ...
Support Center